LYTIR

Company · ALZN

Alzamend Neuro, Inc.

Nasdaq's symbol directory lists ALZN on Nasdaq as “Alzamend Neuro, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders bought on 1 occasion ($111K); insiders sold on 1 occasion ($3K); 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $111K in total; Insider sales: $3K in total.Apr: Insider purchases $111KAug: Insider sales $3KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $111KInsider sales below: $3K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. AULT MILTON C III sold on 1 day bought on 1 day latest Aug 26, 2026 sold $3K · bought $111K
Every trade (2)
  1. SELLAULT MILTON C III sold Aug 26, 2026 2,000 shares filing $3K
  2. BUYAULT MILTON C III bought Apr 14, 2026 110,388 shares 2 legs combined filing $111K

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Sep 29, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.